. 2021 Jan 14;36(2):176–184. doi: 10.46497/ArchRheumatol.2021.8295

Table 2. Pre- and post-treatment comparisons of maximal mouth opening in scleroderma patients.

	Post-treatment 1^st month/baseline			Post-reatment 2^nd month/post-treatment 1^st month
	Maximal mouth opening (mm)	Mean difference (95% CI)	p	Maximal mouth opening (mm)	Mean difference (95% CI)	p
	Mean±SD	Mean difference (95% CI)	p	Mean±SD	Mean difference (95% CI)	p
Group 1	33.0±5.0 / 31.2±4.9	1.94 (1.19-2.69)	<0.001	33.4±5.3 / 33.0±5.0	0.38 (0.44-1.20)	0.352
Group 2	32.9±6.1 / 33.1±5.5	-0.09 (-0.43-0.24)	0.579	34.4±6.5 / 32.9±6.1	1.71 (0.91-2.50)	<0.001
SD: Standard deviation; CI: Confidence interval.